Home \ Expert opinion \ Features of the conduct of elderly patients with chronic brain ischemia

Features of conducting elderly patients with chronic brain ischemia

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

01:30
The main problems of cognitive disorders in the elderly and dementia.
05:04
Scales and identification of the degree of cognitive deficiency
07:14
Screening scales: Mini Cog, a brief scale for assessing mental status, Montreal scale for assessing cognitive functions
10:00
General examination of the patient and the importance of turning on tests in the examination
12:35
Pharmacotherapy of elderly patients on the basis of clinical recommendations
14:40
Criteria for choosing the drug and exclusion of polypragmasis.
15:25
Mexidol® in old age - an effective and safe drug
18:02
The study of the drug Mexidol® on elderly patients. Subanaliz.
20:19
Complex management of a patient with cognitive disorders
21:03
Resource for cognitive training of patients - https://memo.expert/

Ekusheva Evgenia Viktorovna - MD, professor, head. Department of Nervous Diseases and Neurorebition of the Academy of Postgraduate Education of the Federal State Budgetary Educational Institution of the FGBC FMBA of Russia

Mkhitaryan Helene Araikovna - Ph.D., Associate Professor of the Department of Diseases of Style FDPO RNEMU named after N.I. Pirogov MZ of the Russian Federation, head. Laboratory of Neuroheriatry of the RGNCC

Announcement:

Age is a relative concept. In the last century, the age of 60 years seemed already deep old age. Currently, patients are 70+, even 80+, is not uncommon at the doctor. Cognitive disorders can be a sign of serious diseases and require attention from the doctor. Diagnosis of cognitive disorders should begin in the early stages . Mexidol® in old age is an effective and safe drug. The video presents diagnostic methods and the principles of cognitive disorders in patients are disclosed.

All video next video

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

01:30
The main problems of cognitive disorders in the elderly and dementia.
05:04
Scales and identification of the degree of cognitive deficiency
07:14
Screening scales: Mini Cog, a brief scale for assessing mental status, Montreal scale for assessing cognitive functions
10:00
General examination of the patient and the importance of turning on tests in the examination
12:35
Pharmacotherapy of elderly patients on the basis of clinical recommendations
14:40
Criteria for choosing the drug and exclusion of polypragmasis.
15:25
Mexidol® in old age - an effective and safe drug
18:02
The study of the drug Mexidol® on elderly patients. Subanaliz.
20:19
Complex management of a patient with cognitive disorders
21:03
Resource for cognitive training of patients - https://memo.expert/

Block of articles on this topic

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The effectiveness of Mexidol in patients of different age groups with chronic brain ischemia with cognitive disorders (the results of subanalysis of the international multicenter randomized double blind placebo-controlled study of memes)

Authors:
V.V. Zakharov ¹ , O.N. Tkacheva ^2, ³ , E.A. Mkhitaryan ^2, ³ , A.I. Fedin ²

Approaches to pharmacotherapy of vascular moderate cognitive disorders in patients of various age groups

Authors:
V.V. Zakharov ¹ , A.I. Fedin ² , E.A. Mkhitaryan ^2, ³

Mexidol® and Mexidol® Fort 250 as part of the sequential therapy for cognitive disorders in comorbide patients with joint pathology against the background of arterial hypertension and coronary heart disease

Authors:
L.N. Eliseeva, S.V. Kartashova

FSBEI in Kuban State Medical University of the Ministry of Health of Russia, Krasnodar

Features of pharmacotherapy of vascular cognitive impairment in elderly people

Author:
A.N. Bogolepova ^1, ²

¹ FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
² FSBI "Federal Center for Brain and Neurotechnology" of the Federal Medical and Biological Agency of Russia, Moscow, Russia

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com